Literature DB >> 24453758

Psychometric properties of the modified fatigue impact scale.

Rebecca D Larson1.   

Abstract

Psychometric assessments are tests or questionnaires that have been designed to measure constructs of interest in an individual or a target population. A goal of many of these self-report instruments is to provide researchers with the ability to gather subjective information in a manner that might allow for quantitative analysis and interpretation of these results. This requires the instrument of choice to have adequate psychometric properties of reliability and validity. Much research has been conducted on creating self-report quality of life questionnaires for individuals with multiple sclerosis (MS). This article focuses on one in particular, the Modified Fatigue Impact Scale (MFIS). The article starts with a brief description of the rationale, construction, and scoring of the inventory. Next, the best available reliability and validity data on the MFIS are presented. The article concludes with a brief discussion on the interpretation of scores, followed by suggestions for future research. This summative analysis is intended to examine whether the instrument is adequately measuring the impact of fatigue and whether the scores allow for meaningful interpretations.

Entities:  

Year:  2013        PMID: 24453758      PMCID: PMC3883028          DOI: 10.7224/1537-2073.2012-019

Source DB:  PubMed          Journal:  Int J MS Care        ISSN: 1537-2073


  17 in total

1.  Fatigue in multiple sclerosis: a comparison of different rating scales and correlation to clinical parameters.

Authors:  P Flachenecker; T Kümpfel; B Kallmann; M Gottschalk; O Grauer; P Rieckmann; C Trenkwalder; K V Toyka
Journal:  Mult Scler       Date:  2002-12       Impact factor: 6.312

2.  Assessing fatigue in multiple sclerosis: Dutch modified fatigue impact scale.

Authors:  Daphne Kos; Eric Kerckhofs; Guy Nagels; Bie D D'Hooghe; William Duquet; Marijke Duportail; Pierre Ketelaer
Journal:  Acta Neurol Belg       Date:  2003-12       Impact factor: 2.396

Review 3.  Treating fatigue.

Authors:  Y Lapierre; S Hum
Journal:  Int MS J       Date:  2007-06

4.  Observations are always ordinal; measurements, however, must be interval.

Authors:  B D Wright; J M Linacre
Journal:  Arch Phys Med Rehabil       Date:  1989-11       Impact factor: 3.966

5.  Does the Modified Fatigue Impact Scale offer a more comprehensive assessment of fatigue in MS?

Authors:  N Téllez; J Río; M Tintoré; C Nos; I Galán; X Montalban
Journal:  Mult Scler       Date:  2005-04       Impact factor: 6.312

6.  Efficacy and safety of modafinil (Provigil) for the treatment of fatigue in multiple sclerosis: a two centre phase 2 study.

Authors:  K W Rammohan; J H Rosenberg; D J Lynn; A M Blumenfeld; C P Pollak; H N Nagaraja
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-02       Impact factor: 10.154

7.  Modafinil for fatigue in MS: a randomized placebo-controlled double-blind study.

Authors:  B Stankoff; E Waubant; C Confavreux; G Edan; M Debouverie; L Rumbach; T Moreau; J Pelletier; C Lubetzki; M Clanet
Journal:  Neurology       Date:  2005-04-12       Impact factor: 9.910

8.  The impact of fatigue on patients with multiple sclerosis.

Authors:  J D Fisk; A Pontefract; P G Ritvo; C J Archibald; T J Murray
Journal:  Can J Neurol Sci       Date:  1994-02       Impact factor: 2.104

9.  Symptomatic fatigue in multiple sclerosis.

Authors:  J E Freal; G H Kraft; J K Coryell
Journal:  Arch Phys Med Rehabil       Date:  1984-03       Impact factor: 3.966

10.  Exercise capacity, disability and leisure physical activity of subjects with multiple sclerosis.

Authors:  A Romberg; A Virtanen; S Aunola; S L Karppi; H Karanko; J Ruutiainen
Journal:  Mult Scler       Date:  2004-04       Impact factor: 6.312

View more
  33 in total

1.  Clinical relevance of circadian melatonin release in relapsing-remitting multiple sclerosis.

Authors:  Simone Kern; Michael Geiger; Madlen Paucke; Alina Kästner; Katja Akgün; Tjalf Ziemssen
Journal:  J Mol Med (Berl)       Date:  2019-08-30       Impact factor: 4.599

Review 2.  Evaluating the Effects of Dietary Interventions on Disease Progression and Symptoms of Adults with Multiple Sclerosis: An Umbrella Review.

Authors:  Abbey R Tredinnick; Yasmine C Probst
Journal:  Adv Nutr       Date:  2020-11-16       Impact factor: 8.701

3.  Post-stroke fatigue level is significantly associated with mental health component of health-related quality of life: a cross-sectional study.

Authors:  Khader A Almhdawi; Hanan B Jaber; Hanan W Khalil; Saddam F Kanaan; Awni A Shyyab; Zaid M Mansour; Alza H Alazrai
Journal:  Qual Life Res       Date:  2021-01-02       Impact factor: 4.147

Review 4.  Fatigue Can Be Objectively Measured in Multiple Sclerosis: Multipl Sklerozda Yorgunluk Objektif Olarak Ölçülebilir.

Authors:  Haluk Gümüş
Journal:  Noro Psikiyatr Ars       Date:  2018       Impact factor: 1.339

5.  Exploring the feasibility of a mild and short 4-week combined upper limb and breathing exercise program as a possible home base program to decrease fatigue and improve quality of life in ambulatory and non-ambulatory multiple sclerosis individuals.

Authors:  Tanja Grubić Kezele; Matea Babić; Dinko Štimac
Journal:  Neurol Sci       Date:  2019-01-18       Impact factor: 3.307

6.  Adapted physical activity and therapeutic exercise in late-onset Pompe disease (LOPD): a two-step rehabilitative approach.

Authors:  Giovanni Iolascon; Michele Vitacca; Elena Carraro; Carmelo Chisari; Pietro Fiore; Sonia Messina; Tiziana Mongini; Antimo Moretti; Valeria A Sansone; Antonio Toscano; Gabriele Siciliano
Journal:  Neurol Sci       Date:  2019-12-07       Impact factor: 3.307

Review 7.  Central fatigue in multiple sclerosis: a review of the literature.

Authors:  Pamela Newland; Angela Starkweather; Matthew Sorenson
Journal:  J Spinal Cord Med       Date:  2016-05-05       Impact factor: 1.985

8.  Relationship Between Fatigability and Perceived Fatigue Measured Using the Neurological Fatigue Index in People with Multiple Sclerosis.

Authors:  Mayis Aldughmi; Jared Bruce; Catherine F Siengsukon
Journal:  Int J MS Care       Date:  2017 Sep-Oct

9.  Comparison of the Psychometric Properties of Three Fatigue Scales in Persian-Speaking Patients with Multiple Sclerosis.

Authors:  Shabnam Behrangrad; Amin Kordi Yoosefinejad
Journal:  Int J MS Care       Date:  2020-02-14

10.  Altered in vivo brain GABA and glutamate levels are associated with multiple sclerosis central fatigue.

Authors:  Jameen Arm; Georg Oeltzschner; Oun Al-Iedani; Rod Lea; Jeannette Lechner-Scott; Saadallah Ramadan
Journal:  Eur J Radiol       Date:  2021-02-24       Impact factor: 3.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.